Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection
出版年份 2022 全文链接
标题
Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection
作者
关键词
-
出版物
Vaccines
Volume 10, Issue 1, Pages 64
出版商
MDPI AG
发表日期
2022-01-10
DOI
10.3390/vaccines10010064
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Antibody persistence in the first six months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study
- (2021) Arnaud G. L’Huillier et al. CLINICAL MICROBIOLOGY AND INFECTION
- Evolution of antibody immunity to SARS-CoV-2
- (2021) Christian Gaebler et al. NATURE
- Looking beyond COVID-19 vaccine phase 3 trials
- (2021) Jerome H. Kim et al. NATURE MEDICINE
- SARS-CoV-2-directed antibodies persist for more than six months in a cohort with mild to moderate COVID-19
- (2021) Vivian Glück et al. INFECTION
- Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
- (2021) Pengfei Wang et al. NATURE
- Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
- (2021) Adam K. Wheatley et al. Nature Communications
- Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers
- (2021) Marie Tré-Hardy et al. JOURNAL OF INFECTION
- Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice
- (2021) Raoul De Gasparo et al. NATURE
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2
- (2021) Joseph E. Ebinger et al. NATURE MEDICINE
- SARS‐CoV‐2 antibodies started to decline just four months after COVID‐19 infection in a paediatric population
- (2021) Adin Breuer et al. ACTA PAEDIATRICA
- In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
- (2021) Dapeng Li et al. CELL
- SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2
- (2021) Fatima Amanat et al. CELL
- Antibody response to first and second dose of BNT162b2 in a cohort of characterized healthcare workers
- (2021) Andrea Padoan et al. CLINICA CHIMICA ACTA
- SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses
- (2021) Jackson S. Turner et al. NATURE
- Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
- (2021) Zijun Wang et al. NATURE
- Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants
- (2021) Jianliang Xu et al. NATURE
- Present variants of concern and variants of interest of severe acute respiratory syndrome coronavirus 2: Their significant mutations in S‐glycoprotein, infectivity, re‐infectivity, immune escape and vaccines activity
- (2021) Chiranjib Chakraborty et al. REVIEWS IN MEDICAL VIROLOGY
- Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants
- (2021) Amarendra Pegu et al. SCIENCE
- Kinetics of SARS-CoV-2 anti-S IgG after BNT162b2 vaccination
- (2021) Daniel Grupel et al. VACCINE
- One size does not fit all: Lessons from Israel's Covid-19 vaccination drive and hesitancy
- (2021) Aviad Raz et al. VACCINE
- Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan
- (2021) Cesheng Li et al. Nature Communications
- Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains
- (2021) Nikhil Faulkner et al. eLife
- SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
- (2021) Daniel Martínez-Flores et al. Frontiers in Immunology
- Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination
- (2021) Alice Cho et al. NATURE
- Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study
- (2021) Ariel Israel et al. BMJ-British Medical Journal
- Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
- (2020) F. Javier Ibarrondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
- (2020) Ugur Sahin et al. NATURE
- Humoral Immune Response to SARS-CoV-2 in Iceland
- (2020) Daniel F. Gudbjartsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
- (2020) Jeffrey Seow et al. Nature Microbiology
- Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients
- (2020) Anita S. Iyer et al. Science Immunology
- Correlates of protection against SARS-CoV-2 in rhesus macaques
- (2020) Katherine McMahan et al. NATURE
- Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
- (2020) Sheila F. Lumley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exploiting Mucosal Immunity for Antiviral Vaccines
- (2016) Akiko Iwasaki Annual Review of Immunology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started